William Blair & Company’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$421K Sell
77,982
-20
-0% -$120 ﹤0.01% 1205
2025
Q4
$542K Sell
78,002
-775
-1% -$5.1K ﹤0.01% 1118
2025
Q3
$508K Sell
78,777
-2,470
-3% -$16.9K ﹤0.01% 1110
2025
Q2
$541K Sell
81,247
-3,500
-4% -$18K ﹤0.01% 1067
2025
Q1
$548K Buy
84,747
+40
+0% +$287 ﹤0.01% 1061
2024
Q4
$683K Buy
84,707
+2,622
+3% +$21.6K ﹤0.01% 1006
2024
Q3
$670K Sell
82,085
-2,110
-3% -$13.9K ﹤0.01% 1031
2024
Q2
$587K Sell
84,195
-50
-0.1% -$378 ﹤0.01% 1047
2024
Q1
$894K Buy
84,245
+4,000
+5% +$35K ﹤0.01% 905
2023
Q4
$644K Sell
80,245
-27,500
-26% -$200K ﹤0.01% 1002
2023
Q3
$886K Hold
107,745
﹤0.01% 879
2023
Q2
$862K Buy
107,745
+20,225
+23% +$149K ﹤0.01% 888
2023
Q1
$709K Sell
87,520
-3,750
-4% -$30.1K ﹤0.01% 931
2022
Q4
$573K Sell
91,270
-5,400
-6% -$37.7K ﹤0.01% 1001
2022
Q3
$666K Buy
96,670
+25,575
+36% +$178K ﹤0.01% 951
2022
Q2
$594K Sell
71,095
-11,640
-14% -$163K ﹤0.01% 1011
2022
Q1
$1.89M Buy
82,735
+10,590
+15% +$259K 0.01% 711
2021
Q4
$1.99M Sell
72,145
-1,575
-2% -$42.2K 0.01% 731
2021
Q3
$2.05M Buy
73,720
+900
+1% +$25.5K 0.01% 700
2021
Q2
$2.13M Sell
72,820
-48,888
-40% -$1.48M 0.01% 691
2021
Q1
$3.86M Buy
121,708
+55,353
+83% +$1.62M 0.01% 515
2020
Q4
$1.38M Buy
66,355
+795
+1% +$14.8K 0.01% 754
2020
Q3
$1.02M Buy
65,560
+3,285
+5% +$56.6K ﹤0.01% 751
2020
Q2
$1.14M Sell
62,275
-2,600
-4% -$45.8K 0.01% 693
2020
Q1
$1.01M Sell
64,875
-43,300
-40% -$1.04M 0.01% 661
2019
Q4
$3.24M Buy
108,175
+37,100
+52% +$964K 0.02% 500
2019
Q3
$1.55M Buy
71,075
+49
+0.1% +$1.12K 0.01% 644
2019
Q2
$1.79M Buy
71,026
+300
+0.4% +$7.12K 0.01% 604
2019
Q1
$1.75M Sell
70,726
-1,200
-2% -$28.7K 0.01% 597
2018
Q4
$1.33M Buy
+71,926
New +$1.71M 0.01% 615
2018
Q2
Sell
-68,141
Closed -$1.08M 1592
2018
Q1
$1.08M Sell
68,141
-63,800
-48% -$1.19M 0.01% 694
2017
Q4
$2.74M Buy
131,941
+74,600
+130% +$1.18M 0.02% 495
2017
Q3
$822K Sell
57,341
-15,525
-21% -$235K 0.01% 780
2017
Q2
$1.26M Buy
72,866
+26,865
+58% +$322K 0.01% 684
2017
Q1
$649K Buy
46,001
+3,133
+7% +$43.1K 0.01% 823
2016
Q4
$622K Buy
42,868
+2,134
+5% +$39.1K 0.01% 769
2016
Q3
$1M Buy
40,734
+1,100
+3% +$28.5K 0.01% 649
2016
Q2
$798K Buy
39,634
+3,114
+9% +$88.2K 0.01% 693
2016
Q1
$960K Buy
36,520
+1,895
+5% +$140K 0.01% 625
2015
Q4
$3.52M Buy
34,625
+28,675
+482% +$3.22M 0.03% 350
2015
Q3
$1.06M Sell
5,950
-186,245
-97% -$43.4M 0.01% 740
2015
Q2
$42.7M Sell
192,195
-1,140
-0.6% -$253K 0.06% 389
2015
Q1
$38.4M Buy
193,335
+161,301
+504% +$28.6M 0.06% 392
2014
Q4
$4.58M Sell
32,034
-20,599
-39% -$2.77M 0.01% 1063
2014
Q3
$6.91M Sell
52,633
-460
-0.9% -$54.8K 0.01% 946
2014
Q2
$6.7M Sell
53,093
-3,235
-6% -$413K 0.01% 940
2014
Q1
$7.42M Buy
56,328
+7,366
+15% +$1.01M 0.01% 886
2013
Q4
$5.75M Sell
48,962
-45
-0.1% -$4.93K 0.01% 910
2013
Q3
$5.11M Buy
49,007
+65
+0.1% +$6.33K 0.01% 888
2013
Q2
$4.21M Buy
+48,942
New +$3.86M 0.01% 913

Other funds holding BHC

William Blair & Company's BHC Position: Q1 2026 in Review

William Blair & Company reduced its Bausch Health (BHC) stake by 0.03% in Q1 2026, selling an estimated $120 and leaving 77,982 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

William Blair & Company first reported a position in BHC in Q2 2013 and has held it in 50 quarters since. The position peaked at $42.7M in Q2 2015. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • William Blair & Company held 77,982 shares of Bausch Health worth $421K as of Q1 2026.
  • William Blair & Company sold 20 Bausch Health shares in Q1 2026, an estimated $120.
  • Bausch Health made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1205 holding.
  • William Blair & Company first reported a position in Bausch Health in Q2 2013 and has held it in 50 quarters since.
  • William Blair & Company's Bausch Health position peaked at $42.7M in Q2 2015.
  • 228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.